Доступ предоставлен для: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems
Главный редактор: Mandip Sachdeva Singh (open in a new tab)

Выходит 6 номеров в год

ISSN Печать: 0743-4863

ISSN Онлайн: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Drug Delivery by the Intravaginal Route

Том 17, Выпуск 5, 2000, 47 pages
DOI: 10.1615/CritRevTherDrugCarrierSyst.v17.i5.30
Get accessGet access

Краткое описание

The human vagina represents a potential, accessible space that offers a valuable route for drug delivery through the use of specifically designed carrier systems for both local and systemic applications. Intravaginal drug delivery is particularly appropriate for drugs associated with women's health issues but may also have applications in general drug delivery within the female population. A range of drug delivery platforms suitable for intravaginal administration are discussed in this review, including hydrogels, vaginal tablets, pessaries/suppositories, particulate systems, and intravaginal rings. Drug release mechanisms and absorption pathways are reviewed with respect to a range of therapeutic and prophylactic indications for intravaginal delivery.

ЦИТИРОВАНО В
  1. das Neves José, Amaral Maria Helena, Bahia Maria Fernanda, Vaginal Drug Delivery, in Pharmaceutical Sciences Encyclopedia, 2010. Crossref

  2. PADILLA-PAZ Luis Alfonso, Human Papillomavirus Vaccine: History, Immunology, Current Status, and Future Prospects, Clinical Obstetrics and Gynecology, 48, 1, 2005. Crossref

  3. Bermejo Marival, Gonzalez-Alvarez Isabel, How and Where are Drugs Absorbed?, in Pharmaceutical Sciences Encyclopedia, 2010. Crossref

  4. González Zoilo Madrazo, Medayo Luis Secanella, Estaba Leonardo Silvio, Bautista Carla Rojas, Transporte intraabdominal y endovaginal de paquetes de droga (body packer y body pusher), Progresos de Obstetricia y Ginecología, 52, 10, 2009. Crossref

  5. Woolfson A David, Malcolm R Karl, Toner Clare F, Morrow Ryan J, Lowry Deborah, Jamil Asha, McCullagh Stephen D, Potential Use of Vaginal Rings for Prevention of Heterosexual Transmission of HIV, American Journal of Drug Delivery, 4, 1, 2006. Crossref

  6. Klemmt Leah, Scialli Anthony R., The transport of chemicals in semen, Birth Defects Research Part B: Developmental and Reproductive Toxicology, 74, 2, 2005. Crossref

  7. Friend David R., Clark Justin T., Kiser Patrick F., Clark Meredith R., Multipurpose prevention technologies: Products in development, Antiviral Research, 100, 2013. Crossref

  8. Srikrishna Sushma, Cardozo Linda, The vagina as a route for drug delivery: a review, International Urogynecology Journal, 24, 4, 2013. Crossref

  9. Ghosh Tuhin, Chattopadhyay Kausik, Marschall Manfred, Karmakar Paramita, Mandal Pinaki, Ray Bimalendu, Focus on antivirally active sulfated polysaccharides: From structure–activity analysis to clinical evaluation, Glycobiology, 19, 1, 2009. Crossref

  10. Rohan Lisa Cencia, Sassi Alexandra B., Vaginal Drug Delivery Systems for HIV Prevention, The AAPS Journal, 11, 1, 2009. Crossref

  11. Jones Prentiss, Mutsvunguma Romeo, Prahlow Joseph A., Accidental death via intravaginal absorption of methamphetamine, Forensic Science, Medicine, and Pathology, 10, 2, 2014. Crossref

  12. Steinbach Jill M., Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs, Cellular and Molecular Life Sciences, 72, 3, 2015. Crossref

  13. Campaña-Seoane Maria, Peleteiro Aaron, Laguna Reyes, Otero-Espinar Francisco J., Bioadhesive emulsions for control release of progesterone resistant to vaginal fluids clearance, International Journal of Pharmaceutics, 477, 1-2, 2014. Crossref

  14. Wong Tin Wui, Dhanawat Meenakshi, Rathbone Michael John, Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development, Expert Opinion on Drug Delivery, 11, 9, 2014. Crossref

  15. Rosenberg Zeda F., Devlin Brid, Future strategies in microbicide development, Best Practice & Research Clinical Obstetrics & Gynaecology, 26, 4, 2012. Crossref

  16. Baffoe Clara S, Nguyen Nhi, Boyd Peter, Wang Weiguang, Morris Mark, McConville Christopher, Disulfiram-loaded immediate and extended release vaginal tablets for the localised treatment of cervical cancer, Journal of Pharmacy and Pharmacology, 67, 2, 2015. Crossref

  17. Boyd Peter, Major Ian, Wang Weiguang, McConville Christopher, Development of disulfiram-loaded vaginal rings for the localised treatment of cervical cancer, European Journal of Pharmaceutics and Biopharmaceutics, 88, 3, 2014. Crossref

  18. Cu Yen, Booth Carmen J., Saltzman W. Mark, In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery, Journal of Controlled Release, 156, 2, 2011. Crossref

  19. Hussain Alamdar, Ahsan Fakhrul, The vagina as a route for systemic drug delivery, Journal of Controlled Release, 103, 2, 2005. Crossref

  20. Woolfson A. David, Umrethia Manish L., Kett Victoria L., Malcolm R. Karl, Freeze-dried, mucoadhesive system for vaginal delivery of the HIV microbicide, dapivirine: Optimisation by an artificial neural network, International Journal of Pharmaceutics, 388, 1-2, 2010. Crossref

  21. Malcolm Karl, Woolfson David, Russell Julie, Tallon Paul, McAuley Liam, Craig Duncan, Influence of silicone elastomer solubility and diffusivity on the in vitro release of drugs from intravaginal rings, Journal of Controlled Release, 90, 2, 2003. Crossref

  22. Arima Hidetoshi, Motoyama Keiichi, Irie Tetsumi, Recent Findings on Safety Profiles of Cyclodextrins, Cyclodextrin Conjugates, and Polypseudorotaxanes, in Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine, 2011. Crossref

  23. Okura N., Yamagishi N., Naito Y., Kanno K., Koiwa M., Technical Note: Vaginal Absorption of 1,25(OH)2D3 in Cattle, Journal of Dairy Science, 87, 8, 2004. Crossref

  24. Friend David R., Advances in vaginal drug delivery, Drug Delivery and Translational Research, 1, 3, 2011. Crossref

  25. Chiu Ya-Huang, Chan Yi-Lin, Li Tsung-Lin, Wu Chang-Jer, Inhibition of Japanese Encephalitis Virus Infection by the Sulfated Polysaccharide Extracts from Ulva lactuca, Marine Biotechnology, 14, 4, 2012. Crossref

  26. McConville Christopher, Major Ian, Friend David R., Clark Meredith R., Malcolm R. Karl, Development of a UC781 releasing polyethylene vinyl acetate vaginal ring, Drug Delivery and Translational Research, 2, 6, 2012. Crossref

  27. Hardy Ellen, Hebling Eliana M., Sousa Maria H., Almeida Anecy F., Amaral Eliana, Delivery of microbicides to the vagina: difficulties reported with the use of three devices, adherence to use and preferences, Contraception, 76, 2, 2007. Crossref

  28. Morrow Ryan J., Woolfson A. David, Donnelly Louise, Curran Rhonda, Andrews Gavin, Katinger Dietmar, Malcolm R. Karl, Sustained release of proteins from a modified vaginal ring device, European Journal of Pharmaceutics and Biopharmaceutics, 77, 1, 2011. Crossref

  29. Friend David R., Development of controlled release systems over the past 50 years in the area of contraception, Journal of Controlled Release, 240, 2016. Crossref

  30. Friend David R., Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections, Drug Delivery and Translational Research, 1, 3, 2011. Crossref

  31. Friend David R., Pharmaceutical development of microbicide drug products, Pharmaceutical Development and Technology, 15, 6, 2010. Crossref

  32. Friend David R, Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission, Expert Opinion on Drug Delivery, 9, 4, 2012. Crossref

  33. Barreiro-Iglesias Rafael, Alvarez-Lorenzo Carmen, Concheiro Angel, Incorporation of small quantities of surfactants as a way to improve the rheological and diffusional behavior of carbopol gels, Journal of Controlled Release, 77, 1-2, 2001. Crossref

  34. Woolfson A. David, Malcolm R. Karl, Morrow Ryan J., Toner Clare F., McCullagh Stephen D., Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide, International Journal of Pharmaceutics, 325, 1-2, 2006. Crossref

  35. Malcolm R.K, McCullagh S.D, Woolfson A.D, Gorman S.P, Jones D.S, Cuddy J, Controlled release of a model antibacterial drug from a novel self-lubricating silicone biomaterial, Journal of Controlled Release, 97, 2, 2004. Crossref

  36. Woolfson A.D, Malcolm R.K, Gallagher R.J, Design of a silicone reservoir intravaginal ring for the delivery of oxybutynin, Journal of Controlled Release, 91, 3, 2003. Crossref

  37. Malcolm Karl, Woolfson David, Russell Julie, Andrews Chris, In vitro release of nonoxynol-9 from silicone matrix intravaginal rings, Journal of Controlled Release, 91, 3, 2003. Crossref

  38. Machado Rita Monteiro, Palmeira-de-Oliveira Ana, Gaspar Carlos, Martinez-de-Oliveira José, Palmeira-de-Oliveira Rita, Studies and methodologies on vaginal drug permeation, Advanced Drug Delivery Reviews, 92, 2015. Crossref

  39. Mc Conville Christopher, Major Ian, Friend David R., Clark Meredith R., Woolfson A. David, Malcolm R. Karl, Development of polylactide and polyethylene vinyl acetate blends for the manufacture of vaginal rings, Journal of Biomedical Materials Research Part B: Applied Biomaterials, 100B, 4, 2012. Crossref

  40. Johnson Todd J., Gupta Kavita M., Fabian Judit, Albright Theodore H., Kiser Patrick F., Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir, European Journal of Pharmaceutical Sciences, 39, 4, 2010. Crossref

  41. Cheeti Sravanthi, Warrier Bharat K., Lee Chi H., The role of monocarboxylate transporters in uptake of lactic acid in HeLa cells, International Journal of Pharmaceutics, 325, 1-2, 2006. Crossref

  42. Gu Jijin, Ho Emmanuel A., Drug Delivery: Intravaginal, Advantages and Challenges, in Encyclopedia of Biomedical Polymers and Polymeric Biomaterials, 2016. Crossref

  43. Johal Himmat Singh, Garg Tarun, Rath Goutam, Goyal Amit Kumar, Advanced topical drug delivery system for the management of vaginal candidiasis, Drug Delivery, 23, 2, 2016. Crossref

  44. Miscellaneous forms of drug delivery, in Drug Delivery Systems, Second Edition, 2003. Crossref

  45. Eggenreich K., Schrank S., Koscher G., Nickisch K., Roblegg E., Khinast J., Influence of process route on the mechanical properties of polymer based intravaginal drug delivery systems, 1914, 2017. Crossref

  46. Gurman Pablo, Elman Noel, Rosen Yitzhak, Drug Delivery Systems, in Drug Delivery, 2017. Crossref

  47. Mohideen Muneeb, Quijano Elias, Song Eric, Deng Yang, Panse Gauri, Zhang Wei, Clark Meredith R., Saltzman W. Mark, Degradable bioadhesive nanoparticles for prolonged intravaginal delivery and retention of elvitegravir, Biomaterials, 144, 2017. Crossref

  48. Malcolm R. Karl, Woolfson A. David, Toner Clare F., Morrow Ryan J., McCullagh Stephen D., Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings, Journal of Antimicrobial Chemotherapy, 56, 5, 2005. Crossref

  49. Cook Michael T., Brown Marc B., Polymeric gels for intravaginal drug delivery, Journal of Controlled Release, 270, 2018. Crossref

  50. Hassan Abeer S., Soliman Ghareb M., Ali Marwa F., El-Mahdy Mona M., El-Gindy Gamal El-Din A., Mucoadhesive tablets for the vaginal delivery of progesterone: in vitro evaluation and pharmacokinetics/pharmacodynamics in female rabbits, Drug Development and Industrial Pharmacy, 44, 2, 2018. Crossref

  51. Kenechukwu Franklin C., Attama Anthony A., Ibezim Emmanuel C., Nnamani Petra O., Umeyor Chukwuebuka E., Uronnachi Emmanuel M., Gugu Thaddeus H., Momoh Mumuni A., Ofokansi Kenneth C., Akpa Paul A., Surface-modified mucoadhesive microgels as a controlled release system for miconazole nitrate to improve localized treatment of vulvovaginal candidiasis, European Journal of Pharmaceutical Sciences, 111, 2018. Crossref

  52. Veiga-Ochoa María-Dolores, Ruiz-Caro Roberto, Cazorla-Luna Raúl, Martín-Illana Araceli, Notario-Pérez Fernando, Vaginal Formulations for Prevention of Sexual Transmission of HIV, in Advances in HIV and AIDS Control, 2018. Crossref

  53. Aboud Heba M., Hassan Amira H., Ali Adel A., Abdel-Razik Abdel-Razik H., Novel in situ gelling vaginal sponges of sildenafil citrate-based cubosomes for uterine targeting, Drug Delivery, 25, 1, 2018. Crossref

  54. Gupta Deepak, Gupta Sheeba Varghese, Yang Ningning, Understanding the Routes of Administration, in Handbook of Space Pharmaceuticals, 2019. Crossref

  55. Veiga María-Dolores, Ruiz-Caro Roberto, Martín-Illana Araceli, Notario-Pérez Fernando, Cazorla-Luna Raúl, Polymer Gels in Vaginal Drug Delivery Systems, in Polymer Gels, 2018. Crossref

  56. Cheeti Sravanthi, Lee Chi H., The Involvement of Intracellular Calcium in the MCT-Mediated Uptake of Lactic Acid by HeLa Cells, Molecular Pharmaceutics, 7, 1, 2010. Crossref

  57. Alvarez-Lorenzo Carmen, Concheiro Angel, Effects of Surfactants on Gel Behavior, American Journal of Drug Delivery, 1, 2, 2003. Crossref

  58. Moghadam Kenneth K, Williams Daniel B, Advances in Menopausal Hormonal Therapy Delivery Systems, American Journal of Drug Delivery, 3, 1, 2005. Crossref

  59. Fisher Kim, Stiles Carla, Heim Bob, Hagen Neil A., Can Fentanyl be Systemically Absorbed when Administered Vaginally? A Feasibility Study, Journal of Palliative Care, 22, 1, 2006. Crossref

  60. Machado Rita Monteiro, Palmeira-de-Oliveira Ana, Breitenfeld Luiza, Martinez-de-Oliveira José, Palmeira-de-Oliveira Rita, Optimization and Application of In Vitro and Ex Vivo Models for Vaginal Semisolids Safety Evaluation, Journal of Pharmaceutical Sciences, 108, 10, 2019. Crossref

  61. das Neves José, Vaginal Delivery of Biopharmaceuticals, in Mucosal Delivery of Biopharmaceuticals, 2014. Crossref

  62. Lalan Manisha S., Patel Vivek N., Misra Ambikanandan, Polymers in Vaginal Drug Delivery: Recent Advancements, in Applications of Polymers in Drug Delivery, 2021. Crossref

  63. Klasse Per Johan, Shattock Robin, Moore John P., Antiretroviral Drug–Based Microbicides to Prevent HIV-1 Sexual Transmission, Annual Review of Medicine, 59, 1, 2008. Crossref

  64. Ndesendo Valence M. K., Pillay Viness, Choonara Yahya E., Buchmann Eckhart, Bayever David N., Meyer Leith C. R., A Review of Current Intravaginal Drug Delivery Approaches Employed for the Prophylaxis of HIV/AIDS and Prevention of Sexually Transmitted Infections, AAPS PharmSciTech, 9, 2, 2008. Crossref

  65. Ferguson Lindsay M, Rohan Lisa Cencia, The importance of the vaginal delivery route for antiretrovirals in HIV prevention, Therapeutic Delivery, 2, 12, 2011. Crossref

  66. Fetherston Susan M, Malcolm R Karl, Woolfson A David, Controlled-release vaginal ring drug-delivery systems: a key strategy for the development of effective HIV microbicides, Therapeutic Delivery, 1, 6, 2010. Crossref

  67. Wang Lingwei, Zhou Yurui, Wu Menglin, Wu Minghao, Li Xue, Gong Xiaoqun, Chang Jin, Zhang Xuening, Functional nanocarrier for drug and gene delivery via local administration in mucosal tissues, Nanomedicine, 13, 1, 2018. Crossref

  68. Tosca Elena M., Rocchetti Maurizio, Pérez Elena, Nieto Conchi, Bettica Paolo, Moscoso del Prado Jaime, Magni Paolo, De Nicolao Giuseppe, In Vitro–In Vivo Correlation (IVIVC) Population Modeling for the In Silico Bioequivalence of a Long-Acting Release Formulation of Progesterone, Pharmaceutics, 13, 2, 2021. Crossref

  69. McConville Christopher, The therapeutic potential of vaginal drug delivery in the treatment of cervical cancer, Therapeutic Delivery, 6, 5, 2015. Crossref

  70. Stefanidou Martha, Herrera Carolina, Armanasco Naomi, Shattock Robin J., Saquinavir Inhibits Early Events Associated with Establishment of HIV-1 Infection: Potential Role for Protease Inhibitors in Prevention, Antimicrobial Agents and Chemotherapy, 56, 8, 2012. Crossref

  71. Bouchemal Kawthar, Bories Christian, Loiseau Philippe M., Strategies for Prevention and Treatment of Trichomonas vaginalis Infections, Clinical Microbiology Reviews, 30, 3, 2017. Crossref

  72. Dedeloudi Aikaterini, Siamidi Angeliki, Pavlou Panagoula, Vlachou Marilena, Recent Advances in the Excipients Used in Modified Release Vaginal Formulations, Materials, 15, 1, 2022. Crossref

  73. Wilson David P., Coplan Paul M., Wainberg Mark A., Blower Sally M., The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics, Proceedings of the National Academy of Sciences, 105, 28, 2008. Crossref

  74. Johnson Todd J., Clark Meredith R., Albright Theodore H., Nebeker Joel S., Tuitupou Anthony L., Clark Justin T., Fabian Judit, McCabe R. Tyler, Chandra Neelima, Doncel Gustavo F., Friend David R., Kiser Patrick F., A 90-Day Tenofovir Reservoir Intravaginal Ring for Mucosal HIV Prophylaxis, Antimicrobial Agents and Chemotherapy, 56, 12, 2012. Crossref

  75. Gupta Deepak, Gupta Sheeba Varghese, Yang Ningning, Understanding the Routes of Administration, in Handbook of Space Pharmaceuticals, 2022. Crossref

  76. Wang Jiu, Wang Yajing, Wang Ziqiang, Wang Fan, He Jie, Yang Xiaoyun, Xie Weidong, Liu Ying, Zhang Yaou, A thermosensitive gel based on w1/o/w2 multiple microemulsions for the vaginal delivery of small nucleic acid, Drug Delivery, 26, 1, 2019. Crossref

  77. Zimmermann Estevan Sonego, Ferreira Luana Mota, Denardi Laura Bedin, Sari Marcel Henrique Marcondes, Cervi Verônica Ferrari, Nogueira Cristina Wayne, Alves Sydney Hartz, Cruz Letícia, Mucoadhesive gellan gum hydrogel containing diphenyl diselenide-loaded nanocapsules presents improved anti-candida action in a mouse model of vulvovaginal candidiasis, European Journal of Pharmaceutical Sciences, 167, 2021. Crossref

  78. Machado Alexandra, Neves José das, Tissue-based in vitro and ex vivo models for vaginal permeability studies, in Concepts and Models for Drug Permeability Studies, 2016. Crossref

  79. Choudhury Ananta, Kumari Madhusmita, Kumar Dey Biplab, In-Vitro Dissolution Study protocol for various Vaginal Dosage Forms, Research Journal of Pharmacy and Technology, 2022. Crossref

  80. Refai Hanan, Hassan Doaa, Abdelmonem Rehab, Development and characterization of polymer-coated liposomes for vaginal delivery of sildenafil citrate, Drug Delivery, 24, 1, 2017. Crossref

Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции Цены и условия подписки Begell House Контакты Language English 中文 Русский Português German French Spain